Published in Patient on December 01, 2010
Comparing 3 techniques for eliciting patient values for decision making about prostate-specific antigen screening: a randomized controlled trial. JAMA Intern Med (2013) 2.88
Preferences for evidence-based practice dissemination in addiction agencies serving women: a discrete-choice conjoint experiment. Addiction (2012) 1.45
Incorporating patient-preference evidence into regulatory decision making. Surg Endosc (2015) 1.25
Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries. Int J Health Policy Manag (2014) 1.20
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med (2013) 1.16
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis. Patient Prefer Adherence (2013) 1.11
Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther (2014) 1.11
Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care (2015) 1.08
Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis. Osteoporos Int (2012) 0.98
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment. Patient (2016) 0.96
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients. Interact J Med Res (2015) 0.94
Impact of educational and patient decision aids on decisional conflict associated with total knee arthroplasty. Arthritis Care Res (Hoboken) (2012) 0.92
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study. BMJ Open (2012) 0.90
Clinical factors and the decision to transfuse chronic dialysis patients. Clin J Am Soc Nephrol (2013) 0.90
Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting. BMC Med Inform Decis Mak (2015) 0.90
Patients' & healthcare professionals' values regarding true- & false-positive diagnosis when colorectal cancer screening by CT colonography: discrete choice experiment. PLoS One (2013) 0.89
Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment. BMC Public Health (2013) 0.89
Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis. BMC Health Serv Res (2012) 0.88
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Support Care Cancer (2014) 0.88
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK. Patient Prefer Adherence (2015) 0.84
Consumer preferences for hearing aid attributes: a comparison of rating and conjoint analysis methods. Trends Amplif (2012) 0.84
Measuring the Preferences of Homeless Women for Cervical Cancer Screening Interventions: Development of a Best-Worst Scaling Survey. Patient (2015) 0.83
Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res (2011) 0.83
Towards personalizing treatment for depression : developing treatment values markers. Patient (2013) 0.83
An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening. BMC Med Res Methodol (2012) 0.82
Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther (2013) 0.82
The development of ORACLe: a measure of an organisation's capacity to engage in evidence-informed health policy. Health Res Policy Syst (2016) 0.81
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST). Patient Prefer Adherence (2011) 0.81
The effect of out-of-pocket costs and financial rewards in a discrete choice experiment: an application to lifestyle programs. BMC Public Health (2014) 0.81
Quantifying public preferences for different bowel preparation options prior to screening CT colonography: a discrete choice experiment. BMJ Open (2014) 0.81
The effect of including an opt-out option in discrete choice experiments. PLoS One (2014) 0.80
Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues. Health Econ Rev (2016) 0.79
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers. Orphanet J Rare Dis (2016) 0.78
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan. Patient Prefer Adherence (2016) 0.78
A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia. BMJ Open (2014) 0.78
Simulation study to determine the impact of different design features on design efficiency in discrete choice experiments. BMJ Open (2016) 0.77
Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol (2015) 0.77
Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments. J Thyroid Res (2015) 0.77
The relative importance of perceived doctor's attitude on the decision to consult for symptomatic osteoarthritis: a choice-based conjoint analysis study. BMJ Open (2015) 0.77
Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment. PLoS One (2014) 0.76
Using conjoint analysis to develop a system of scoring policymakers' use of research in policy and program development. Health Res Policy Syst (2015) 0.76
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment. Patient (2016) 0.75
Understanding Preferences for Treatment After Hypothetical First-Time Anterior Shoulder Dislocation: Surveying an Online Panel Utilizing a Novel Shared Decision-Making Tool. Orthop J Sports Med (2017) 0.75
PROSpER: PReferences for the Organisation of acute health Services for oldER people: protocol for a mixed methods study. BMJ Open (2012) 0.75
The value of quantitative patient preferences in regulatory benefit-risk assessment. J Mark Access Health Policy (2014) 0.75
Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment. Appl Health Econ Health Policy (2016) 0.75
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors. Patient (2016) 0.75
Hemodialysis patients' preferences for the management of anemia. BMC Nephrol (2017) 0.75
Older People's Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment. Drugs Aging (2017) 0.75
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health (2013) 2.82
Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res (2002) 2.36
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res (2002) 1.75
Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med (2004) 1.66
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
Overcoming bias in estimating the volume-outcome relationship. Health Serv Res (2006) 1.26
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17
Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res (2012) 1.14
Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol (2011) 1.12
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management. J Manag Care Pharm (2010) 1.11
Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine (2009) 1.09
A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation. Patient (2012) 1.07
Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis (2014) 1.05
Risking health to avoid injections: preferences of Canadians with type 2 diabetes. Diabetes Care (2005) 1.04
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res (2006) 0.96
Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDS (2009) 0.96
Identifying possible indicators of systematic overuse of health care procedures with claims data. Med Care (2014) 0.95
Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis. Patient (2015) 0.94
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Hypothetical bias, cheap talk, and stated willingness to pay for health care. J Health Econ (2009) 0.94
Estimating older adults' preferences for walking programs via conjoint analysis. Am J Prev Med (2009) 0.94
Patient preferences for the treatment of type 2 diabetes: a scoping review. Pharmacoeconomics (2013) 0.92
Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol (2012) 0.89
Can public reporting impact patient outcomes and disparities? A systematic review. Patient Educ Couns (2013) 0.89
Using comparative effectiveness research to inform decision-making: is there a role of economic evaluation? J Comp Eff Res (2012) 0.89
Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care (2012) 0.89
Clopidogrel and percutaneous coronary interventions. JAMA (2003) 0.88
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient (2013) 0.87
Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment. Int J Technol Assess Health Care (2009) 0.86
Editorial: Moving the QALY forward or just stuck in traffic? Value Health (2009) 0.86
How do physicians weigh benefits and risks associated with treatments in patients with osteoarthritis in the United Kingdom? J Rheumatol (2012) 0.85
Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies. Ann Pharmacother (2010) 0.85
Einstein on willingness to pay per QALY: is there a better way? Med Decis Making (2005) 0.85
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications. Allergy Asthma Proc (2009) 0.84
Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis. Med Decis Making (2011) 0.84
Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution. Environ Health (2002) 0.83
Assessing the impact of palliative care in the intensive care unit through the lens of patient-centered outcomes research. Curr Opin Crit Care (2013) 0.83
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome. Value Health (2009) 0.83
Comparison of individual and group valuation of health state scenarios across communities in West Africa. Appl Health Econ Health Policy (2006) 0.83
What outcomes should US policy makers compare in comparative effectiveness research? Expert Rev Pharmacoecon Outcomes Res (2010) 0.83
Functional status decline as a measure of adverse events in home health care: an observational study. BMC Health Serv Res (2006) 0.82
Reducing disparities in breast cancer survival--the effect of large-scale screening of the uninsured. Breast J (2011) 0.82
Patients' preferences for healthcare system reforms in Hungary: a conjoint analysis. Appl Health Econ Health Policy (2006) 0.82
Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther (2013) 0.82
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Healthy-days time equivalents for outcomes of acute rotavirus infections. Vaccine (2011) 0.81
A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatr Serv (2014) 0.80
Women's willingness to accept perceived risks for vasomotor symptom relief. J Womens Health (Larchmt) (2007) 0.80
Who pays attention in stated-choice surveys? Health Econ (2010) 0.79
An environmental scan of advance care planning decision AIDS for patients undergoing major surgery: a study protocol. Patient (2014) 0.79
Estimating importance weights for the IWQOL-Lite using conjoint analysis. Qual Life Res (2010) 0.79
The association between amalgam dental surfaces and urinary mercury levels in a sample of Albertans, a prevalence study. J Occup Med Toxicol (2013) 0.79
Patient preferences and linear scoring rules for patient-reported outcomes. Patient (2010) 0.78
Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and Germany. Qual Life Res (2014) 0.78
Group decision making with the analytic hierarchy process in benefit-risk assessment: a tutorial. Patient (2014) 0.78
Assessing comparative effectiveness research in the US. Appl Health Econ Health Policy (2009) 0.78
Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. Eur J Gastroenterol Hepatol (2012) 0.77
The role of the patient in promoting patient-centered outcomes research. Patient (2008) 0.77
Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh. Int J Technol Assess Health Care (2008) 0.77
Understanding consumer preferences in the context of managed competition: evidence from a choice experiment in Colombia. Appl Health Econ Health Policy (2012) 0.77
Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. Psychiatr Serv (2014) 0.77
Voluntary versus involuntary waiting for joint replacements: new Alberta wait times rules for hip and knee arthroplasties, with provincial consensus. Healthc Q (2012) 0.77
Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. Adv Health Econ Health Serv Res (2014) 0.77
An index for measuring overuse of health care resources with Medicare claims. Med Care (2015) 0.76
Determinants of influenza vaccine purchasing decision in the US: a conjoint analysis. Vaccine (2010) 0.76
Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma. Ann Surg Oncol (2014) 0.76
Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease. Alzheimer Dis Assoc Disord (2009) 0.76
A comparison of two experimental design approaches in applying conjoint analysis in patient-centered outcomes research: a randomized trial. Patient (2012) 0.76
Caregiver Preferences for the Treatment of Males with Fragile X Syndrome. J Dev Behav Pediatr (2016) 0.76
Development and pilot study of a marketing strategy for primary care/internet-based depression prevention intervention for adolescents (the CATCH-IT intervention). Prim Care Companion J Clin Psychiatry (2010) 0.76
Factors in studying patient-physician communication. JAMA (2003) 0.75
Improving End-of-Life Decision-Making About Resuscitation and Intubation. J Gen Intern Med (2015) 0.75
Modeling for health care and other policy decisions: uses, roles, and validity. Value Health (2002) 0.75
Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr (2017) 0.75
The cost-effectiveness of a law banning the use of cellular phones by drivers. Health Econ (2010) 0.75
Stakeholder perspectives on European priorities for comprehensive liver cancer control: a conjoint analysis. Eur J Public Health (2013) 0.75
A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens. Pharmacoeconomics (2002) 0.75
Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. Pharmacoeconomics (2006) 0.75
Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment. Headache (2013) 0.75
Systematic overuse of healthcare services: a conceptual model. Appl Health Econ Health Policy (2015) 0.75